Gemcitabine and docetaxel as first-line treatment for advanced urothelial carcinoma: a phase II study

por Ardavanis, A, Tryfonopoulos, D, Alexopoulos, A, Kandylis, C, Lainakis, G, Rigatos, G
Publicado 2005

Overexpression of matrix-metalloproteinase-9 in human breast cancer: a potential favourable indicator in node-negativeatients

por Scorilas, A, Karameris, A, Arnogiannaki, N, Ardavanis, A, Bassilopoulos, P, Trangas, T, Talieri, M
Publicado 2001

Vaccine third dose and cancer patients: necessity or luxury?

por Pappas, G., Saloustros, E., Boutis, A., Tsoukalas, N., Nikolaou, M., Christopoulou, A., Agelaki, S., Boukovinas, I., Ardavanis, A., Saridaki, Z.
Publicado 2021

Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre,...

por Georgoulias, V, Kouroussis, C, Agelidou, A, Boukovinas, I, Palamidas, P, Stavrinidis, E, Polyzos, A, Syrigos, K, Veslemes, M, Toubis, M, Ardavanis, A, Tselepatiotis, E, Vlachonikolis, I
Publicado 2004